Watson Fund, L.P.: A healthcare venture capital fund specializing in early-stage life science investments.
Location
Seattle, WA, US
Founded
2013
Watson Fund, L.P. is a healthcare venture capital firm specializing in early-stage investments across a broad range of life science opportunities. The fund primarily invests in ventures developed and managed by Accelerator Corporation, while reserving capital for follow-on investments in companies meeting predefined milestones. Watson Fund typically participates in Series A and Series B funding rounds.
Notable portfolio companies include ApoGen Biotechnologies, Magnolia Neurosciences, Petra Pharma, and Proniras. The fund's investment strategy focuses on supporting promising healthcare and life science startups through their critical early stages of development. Watson Fund's partnership with Accelerator Corporation provides a unique value proposition for its portfolio companies, potentially offering additional resources and expertise in the life sciences sector.
Watson Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count2
Top Investment Stages
Series A3 (75.0%)
Series B1 (25.0%)
Stage Mix
Series A 75%Series B 25%
Concentration shown as share of disclosed investments by stage.